adenylyl imidodiphosphate has been researched along with Di Guglielmo Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bjorndahl, JM; Cone, JC; Dombrowski, KE; Phillips, CA | 1 |
| Fagan, JM; Goldberg, AL; Tanaka, K; Waxman, L | 1 |
2 other study(ies) available for adenylyl imidodiphosphate and Di Guglielmo Disease
| Article | Year |
|---|---|
Irreversible inhibition of human natural killer cell natural cytotoxicity by modification of the extracellular membrane by the adenine nucleotide analog 5'-p-(fluorosulfonyl)benzoyl adenosine.
Topics: Adenosine; Adenosine Diphosphate; Adenosine Triphosphate; Adenylyl Imidodiphosphate; Benzoates; Burkitt Lymphoma; Cell Line; Cell Membrane; Cytoplasmic Granules; Cytotoxicity, Immunologic; Extracellular Space; Granzymes; Humans; Immunosuppressive Agents; Killer Cells, Natural; Leukemia, Erythroblastic, Acute; Phenylmethylsulfonyl Fluoride; Serine Endopeptidases; Tumor Cells, Cultured | 1995 |
A soluble ATP-dependent system for protein degradation from murine erythroleukemia cells. Evidence for a protease which requires ATP hydrolysis but not ubiquitin.
Topics: Adenosine Triphosphate; Adenylyl Imidodiphosphate; Animals; Cell Line; Ethylmaleimide; Heme; High Mobility Group Proteins; Isoflurophate; Kinetics; Leukemia, Erythroblastic, Acute; Leukemia, Experimental; Mice; Peptide Hydrolases; Proteins; Rabbits; Reticulocytes; Ubiquitins | 1985 |